This Is Why I’d Sell RSA Insurance Group plc Today

RSA Insurance Group plc (LON:RSA) is a sell, says Roland Head, who believes the insurer’s shares remain overpriced.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

What do you call a company that’s cut its dividend by 33%, issued a profit warning, and accepted the resignation of its Ireland chief executive on suspicion of accounting irregularities, all in the space of 12 months?

In this case, the answer is RSA Insurance Group (LSE: RSA) (NASDAQOTH: RSANY.US), a firm whose share price has declined by 19% so far this year — so much so that its prospective dividend yield has risen above 6% once more, despite the cuts to its payout.

The resignation of RSA Ireland CEO Philip Smith following allegations of accounting irregularities is the latest below to shareholders, and the episode is expected to cost the firm £70m in lost operating profits.

Indeed, over the last five years, RSA investors have seen the value of their shares fall by 29% — compared to a 61% gain for the FTSE 100, and a 17% gain for RSA’s UK peer Aviva.

Despite all of this, short term bad news, such as RSA’s recent weather-induced profit warning, isn’t necessarily a reason to sell a stock. Indeed, it can be a good buying opportunity — so why do I rate RSA shares as a sell?

Just not cheap enough

RSA’s net asset value per share was 99p at the start of November, down from 103p in August and 107p at the end of last year.  None of these figures include RSA’s pension deficit, which was valued at £442m in July — a sum which equates to 12p a share. RSA has agreed to reduce this deficit with additional payments of between £60m and £70m per year until 2016, placing more pressure on its profits.

Given RSA’s patchy track record, I wouldn’t buy the insurer’s shares today unless they traded at a discount to their net asset value — and given this year’s slide in net asset value, I’d want a decent margin of safety, too, in case the fall continues.

In my view, RSA would be good value at around 95p, which would place them on a 2013 forecast P/E of 12, still a considerable premium to Aviva, whose shares currently trade on a 2013 forecast P/E of 9.7.

A better buy for income?

RSA enjoyed a strong reputation with income investors who believed its dividend wouldn’t be cut. That belief is now history and with limited cash flow to cover the firm’s dividend payout, a further cut isn’t impossible.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

 > Roland owns shares in Aviva, but does not own shares in RSA Insurance Group.

More on Investing Articles

A pastel colored growing graph with rising rocket.
Investing Articles

Is this FTSE growth superstar set to soar even higher on new drug results?

New drugs should significantly boost this FTSE stock’s earnings in my view. But even without them it looked very undervalued…

Read more »

Investing Articles

As revenues fall 9% and profits drop 53%, why is the Tesla share price going up?

The Tesla share price is rising after its earnings report for the start of 2024. What’s causing the stock to…

Read more »

Investing Articles

1 monster growth stock down 23% I’d buy on the dip and hold for years

Our writer thinks there's a great potential investment opportunity in this growth stock and he'd strike while the iron's hot……

Read more »

Investing For Beginners

How investing £800 a month could help me live off my second income

Jon Smith explains how he can make a second income to live off later in life and shares one stock…

Read more »

The Milky Way at night, over Porthgwarra beach in Cornwall
Investing Articles

Forget investing for the next five years, 5 stocks that can last forever

Two US-listed stocks, and three right here in Blighty -- find out the names of five businesses that have our…

Read more »

Young Black man sat in front of laptop while wearing headphones
Investing Articles

Investing just £10 a day in UK stocks could bag me a passive income stream of £267 a week!

This Fool explains how investing in UK stocks rather than buying a couple of takeaway coffees a day could help…

Read more »

Investing Articles

A cheap stock to consider buying as the FTSE 100 hits all-time highs

Roland Head explains why the FTSE 100 probably isn’t expensive and highlights a cheap dividend share to consider buying today.

Read more »

Investing Articles

If I were retiring tomorrow, I’d snap up these 3 passive income stocks!

Our writer was recently asked which passive income stocks she’d be happy to buy if she were to retire tomorrow.…

Read more »